Koya Medical recently received FDA-clearance for the Dayspring™ product platform, a prescription only active wearable compression system for the treatment of lymphedema.
Koya Medical Closes $11M Financing to Accelerate Treatment for Lymphedema
Category: Startup News
Nanochon raising new funding for its 3D-printed implant
Nanochon’s technology replaces lost or damaged cartilage as an alternative to replacement surgeries.
Tangible Boost Receives FDA Clearance
Tangible Boost is a monthly treatment that restores the coating and maintains the wettability of Tangible’s proprietary rigid gas-permeable contact lenses.
ConsejoSano raises $17M, prepares for vaccine rollout
ConsejoSano, recently selected for the Rosenman ADAPT program, raised $17 million in series B funding. The startup’s focus is to better communicate with patients based on their cultural background.
Kenota Health raises $11M in Funding to Bring Point-of-Care Allergy Testing to Healthcare Clinics
Kenota provides allergy specialists with a new approach to allergy testing, which takes less than 30 minutes and requires just a few drops of blood from a quick finger prick.
FDA clears Allotrope’s StimSite™
StimSite provides ob/gyns, general and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation.
GT Medical Technologies Announces First Patient Treated in Registry Trial of GammaTile Therapy for Brain Tumors
Study to Enroll 600 Patients and Evaluate Real-World Clinical and Patient Reported Outcomes Across All Brain Tumor Types
– First Patient Enrolled by Vidant Health in Greenville, N.C.
Bringing Healthtech Startups and Leading Payers Together to Catalyze Innovation: UCSF Rosenman Institute Announces Companies Chosen for “ADAPT” Program
Seven Startups Selected from Global Field, Matched with Three Leading U.S. Healthcare Payers for Support and Funding
SDIP Innovations Wins $2.7M Grant from NSW Health
The funding will advance R&D on the JAZBI™ bioresorbable implant system. The award also provides access to the NSW healthcare system resources and critical insights from NSW Health medical devices expert panel.
Cala Health Wins FDA Breakthrough Nod for Tremor Treating Therapy
Cala Health announced that it had received FDA breakthrough device designation for its Cala Trio treatment for action tremors in people with Parkinson’s disease.